Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors' Dealings notification transmitted by DGAP – a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Details of the person subject to the disclosure requirement Last name: Dr. Ramroth First name: Michael Company: Biotest AG Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE0005227235 Type of transaction: Purchase Date: 11.02.2016 Price: 11.474 Currency: EUR No. of items: 1500 Total amount traded: 17211.00 Place: Frankfurt Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Germany ISIN: DE0005227235 WKN: 522723 End of Directors' Dealings Notification (c) DGAP 11.02.2016 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 24431
DGAP-DD: Biotest AG english
| Source: EQS Group AG